Trial Profile
Evaluation the clinical trial of Rituximab (Zytux) efficacy in improving the skin stiffness and lung involvements of the patients with diffuse cutaneous Systemic sclerosis with diffuse skin involvement
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 20 Sep 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Diphenhydramine; Hydrocortisone
- Indications Scleroderma
- Focus Adverse reactions
- Sponsors AryoGen Pharmed
- 20 Sep 2016 New trial record